Wei Dai

Dr. Wei Dai

Department of Clinical Oncology, University of Hong Kong, Hong Kong SAR, China
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2012 in Oncogene
Verified
Journal Article
Closed access
CZC Zeller
C Zeller
WDWei Dai
Wei Dai
NSN L Steele
N L Steele
ASA Siddiq
A Siddiq
AWA J Walley
A J Walley
RBRobert Brown
Robert Brown

9 March 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
LGLanqi Gong
Lanqi Gong
DKDora Lai-Wan Kwong
Dora Lai-Wan Kwong
WDWei Dai
Wei Dai
PWPingan Wu
Pingan Wu
SLShanshan Li
Shanshan Li
Xin-Yuan GuanXin-Yuan Guan
Xin-Yuan Guan
The tumor microenvironment (TME) of nasopharyngeal carcinoma (NPC) harbors a heterogeneous and dynamic stromal population. A comprehensive understanding of this tumor-specific ecosystem is necessary to enhance cancer diagnosis, therapeutics, and prognosis. However, recent advances based on bulk RNA sequencing remain insufficient to construct an in-depth landscape of infiltrating stromal cells in NPC. Here we apply single-cell RNA sequencing to 66,627 cells from 14 patients, integrated with clonotype identification on T and B cells. We identify and characterize five major stromal clusters and 36 distinct subpopulations based on genetic profiling. By comparing with the infiltrating cells in the non-malignant microenvironment, we report highly representative features in the TME, including phenotypic abundance, genetic alternations, immune dynamics, clonal expansion, developmental trajectory, and molecular interactions that profoundly influence patient prognosis and therapeutic outcome. The key findings are further independently validated in two single-cell RNA sequencing cohorts and two bulk RNA-sequencing cohorts. In the present study, we reveal the correlation between NPC-specific characteristics and progression-free survival. Together, these data facilitate the understanding of the stromal landscape and immune dynamics in NPC patients and provides deeper insights into the development of prognostic biomarkers and therapeutic targets in the TME.

1 February 2011 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
PDF file
SRSiân Rizzo
Siân Rizzo
JHJenny M. Hersey
Jenny M. Hersey
PMPaul Mellor
Paul Mellor
WDWei Dai
Wei Dai
ASAlessandra Santos-Silva
Alessandra Santos-Silva
RBRobert Brown
Robert Brown
Platinum-based chemotherapy, with cytoreductive surgery, is the cornerstone of treatment of advanced ovarian cancer; however, acquired drug resistance is a major clinical obstacle. It has been proposed that subpopulations of tumor cells with stem cell–like properties, such as so-called side populations (SP) that overexpress ABC drug transporters, can sustain the growth of drug-resistant tumor cells, leading to tumor recurrence following chemotherapy. The histone methyltransferase EZH2 is a key component of the polycomb-repressive complex 2 required for maintenance of a stem cell state, and overexpression has been implicated in drug resistance and shorter survival of ovarian cancer patients. We observed higher percentage SP in ascites from patients that have relapsed following chemotherapy compared with chemonaive patients, consistent with selection for this subpopulation during platinum-based chemotherapy. Furthermore, ABCB1 (P-glycoprotein) and EZH2 are consistently overexpressed in SP compared with non-SP from patients' tumor cells. The siRNA knockdown of EZH2 leads to loss of SP in ovarian tumor models, reduced anchorage-independent growth, and reduced tumor growth in vivo. Together, these data support a key role for EZH2 in the maintenance of a drug-resistant, tumor-sustaining subpopulation of cells in ovarian cancers undergoing chemotherapy. As such, EZH2 is an important target for anticancer drug development. Mol Cancer Ther; 10(2); 325–35. ©2010 AACR.

19 September 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HZHong Zheng
Hong Zheng
WDWei Dai
Wei Dai
ACArthur Kwok Leung Cheung
Arthur Kwok Leung Cheung
JKJosephine Ko
Josephine Ko
RKRebecca Kan
Rebecca Kan
MLMaria Li Lung
Maria Li Lung
Significance: Host genetics, environmental factors, and EBV infection together contribute to nasopharyngeal carcinoma (NPC) development. A number of critical genetic and epigenetic events contributing to tumor development has been reported. However, the genomic alterations in NPC have not been completely deciphered. We used the whole-exome sequencing approach to study the somatic mutations in NPC, and an APOBEC-mediated mutagenesis signature was revealed. Importantly, multiple loss-of-function mutations in the NF-κB–negative regulators (NFKBIA,CYLD, andTNFAIP3) were discovered in NPC tumors, and we functionally confirmed that theNFKBIAloss-of-function mutations induce damaging effects on the WT proteins. Detection of these mutations emphasizes the critical role of NF-κB signaling in NPC tumorigenesis and provides perspectives for targeting this pathway in NPC treatment.

7 November 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
WLWeitao Lin
Weitao Lin
YYYim Ling Yip
Yim Ling Yip
LJLin Jia
Lin Jia
WDWen Deng
Wen Deng
HZHong Zheng
Hong Zheng
STSai Wah Tsao
Sai Wah Tsao
The lack of representative nasopharyngeal carcinoma (NPC) models has seriously hampered research on EBV carcinogenesis and preclinical studies in NPC. Here we report the successful growth of five NPC patient-derived xenografts (PDXs) from fifty-eight attempts of transplantation of NPC specimens into NOD/SCID mice. The take rates for primary and recurrent NPC are 4.9% and 17.6%, respectively. Successful establishment of a new EBV-positive NPC cell line, NPC43, is achieved directly from patient NPC tissues by including Rho-associated coiled-coil containing kinases inhibitor (Y-27632) in culture medium. Spontaneous lytic reactivation of EBV can be observed in NPC43 upon withdrawal of Y-27632. Whole-exome sequencing (WES) reveals a close similarity in mutational profiles of these NPC PDXs with their corresponding patient NPC. Whole-genome sequencing (WGS) further delineates the genomic landscape and sequences of EBV genomes in these newly established NPC models, which supports their potential use in future studies of NPC.

1 April 2016 in Chinese Clinical Oncology
Verified
Journal Article
Open access
WDWei Dai
Wei Dai
HZHong Zheng
Hong Zheng
ACArthur Kwok Leung Cheung
Arthur Kwok Leung Cheung
MLMaria Li Lung
Maria Li Lung
Nasopharyngeal carcinoma (NPC) is a unique epithelial malignancy that shows a remarkable geographical and ethic distribution. Multiple factors including predisposing genetic factors, environmental carcinogens, and Epstein-Barr virus (EBV) infection contribute to the accumulation of genetic and epigenetic alterations leading to NPC development. Emerging technologies now allow us to detailedly characterize and understand cancer genomes. Genome-wide studies show that typically NPC tumors are characterized as having comparatively low mutation rates, widespread hypermethylation, and frequent copy number alterations and chromosome abnormalities. In this review, we provide an updated overview of the genetic and epigenetic aberrations that likely drive nasopharyngeal tumor development and progression. We integrate the previous knowledge and novel findings from whole-exome sequencing (WES) and methylome studies in NPC, and further discuss the potential use of these findings to identify biomarkers for NPC diagnosis and prognosis.